The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy
Open accessAbstract
With the goal of identifying genes with a differential pattern of expression between ovarian serous papillary carcinomas (OSPCs) and normal ovarian (NOVA) epithelium and using this knowledge for the development of novel diagnostic and therapeutic markers for ovarian cancer, we used oligonucleotide microarrays with probe sets complementary to 12,533 genes to analyze the gene expression profiles of 10 primary OSPC cell lines, 2 established OSPC cell lines (UCI‐101, UCI‐107) and 5 primary NOVA epithelial cultures. Unsupervised analysis of gene expression data identified 129 and 170 genes that exhibited >5‐fold upregulation and downregulation, respectively, in primary OSPC compared to NOVA. Genes overexpressed in established OSPC cell lines had little correlation with those overexpressed in primary OSPC, highlighting the divergence of gene expression that occurs as a result of long‐term in vitro growth. Hierarchical clustering of the expression data readily distinguished normal tissue from primary OSPC. Laminin, claudin 3, claudin 4, tumor‐associated calcium signal transducers 1 and 2 (TROP‐1/Ep‐CAM, TROP‐2), ladinin 1, S100A2, SERPIN2 (PAI‐2), CD24, lipocalin 2, osteopontin, kallikrein 6 (protease M), kallikrein 10, matriptase (TADG‐15) and stratifin were among the most highly overexpressed genes in OSPC compared to NOVA. Downregulated genes in OSPC included transforming growth factor‐β receptor III, platelet‐derived growth factor receptor α, SEMACAP3, ras homolog gene family member I (ARHI), thrombospondin 2 and disabled‐2/differentially expressed in ovarian carcinoma 2 (Dab2/DOC2). Differential expression of some of these genes, including claudin 3, claudin 4, TROP‐1 and CD24, was validated by quantitative RT‐PCR and flow cytometry on primary OSPC and NOVA. Immunohistochemical staining of formalin‐fixed, paraffin‐embedded tumor specimens from which primary OSPC cultures were derived further confirmed differential expression of CD24 and TROP‐1/Ep‐CAM markers on OSPC vs. NOVA. These results, obtained with highly purified primary cultures of ovarian cancer, highlight important molecular features of OSPC and may provide a foundation for the development of new type‐specific therapies against this disease. © 2004 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., & Thun, M. J. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.1.5 · Cited by 3,275
The lipocalin protein family: structure and function
FLOWER, D. R. (1996) · Biochemical Journal · doi:10.1042/bj3180001 · Cited by 1,679
Morita, K., Furuse, M., Fujimoto, K., & Tsukita, S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.511 · Cited by 1,126
Welsh, J. B., Zarrinkar, P. P., Sapinoso, L. M., Kern, S. G., Behling, C. A., Monk, B. J., Lockhart, D. J., Burger, R. A., & Hampton, G. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1176 · Cited by 654
Zhan, F., Hardin, J., Kordsmeier, B., Bumm, K., Zheng, M., Tian, E., Sanderson, R., Yang, Y., Wilson, C., Zangari, M., et al. (2002) · Blood · doi:10.1182/blood.v99.5.1745 · Cited by 638
Self-citationYIGSR, a Synthetic Laminin Pentapeptide, Inhibits Experimental Metastasis Formation
Iwamoto, Y., Robey, F. A., Graf, J., Sasaki, M., Kleinman, H. K., Yamada, Y., & Martin, G. R. (1987) · Science · doi:10.1126/science.2961059 · Cited by 552
Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule.
Litvinov, S. V., Velders, M. P., Bakker, H. A., Fleuren, G. J., & Warnaar, S. O. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.2.437 · Cited by 524
Riethmüller, G., Holz, E., Schlimok, G., Schmiegel, W., Raab, R., Höffken, K., Gruber, R., Funke, I., Pichlmaier, H., Hirche, H., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.5.1788 · Cited by 517
Hough, C. D., Sherman‐Baust, C. A., Pizer, E. S., Montz, F. J., Im, D. D., Rosenshein, N. B., Cho, K. R., Riggins, G. J., & Morin, P. J. (2000) · PubMed · Cited by 502
Osteopontin as a Potential Diagnostic Biomarker for Ovarian Cancer
Kim, J.-H. (2002) · JAMA · doi:10.1001/jama.287.13.1671 · Cited by 480
Koeneman, K. S., Yeung, F., & Chung, L. W. K. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990601)39:4<246::aid-pros5>3.0.co;2-u · Cited by 440
Schwartz, D. R., Kardia, S. L. R., Shedden, K., Kuick, R. D., Michailidis, G. C., Taylor, J. M. G., Misek, D. E., WU, R. T., Zhai, Y., Darrah, D. M., et al. (2002) · PubMed · Cited by 430
CD24, a Mucin-Type Glycoprotein, Is a Ligand for P-Selectin on Human Tumor Cells
Aigner, S., Sthoeger, Z. M., Fogel, M., Weber, E., Zarn, J., Ruppert, M., Zeller, Y., Vestweber, D., Stahel, R., Sammar, M., et al. (1997) · Blood · doi:10.1182/blood.v89.9.3385 · Cited by 325
Identification by cDNA microarray of genes involved in ovarian carcinogenesis.
Ono, K., Tanaka, T., Tsunoda, T., Kitahara, O., Kihara, C., Okamoto, A., Ochiai, K., Takagi, T., & Nakamura, Y. (2000) · PubMed · Cited by 307
CD24 mediates rolling of breast carcinoma cells on P‐selectin
Aigner, S., Ramos, C. L., Hafezi‐Moghadam, A., Lawrence, M. B., Friederichs, J., Altevogt, P., & Ley, K. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1241 · Cited by 282
Coordinately up-regulated genes in ovarian cancer.
Hough, C. D., Cho, K. R., Zonderman, A. B., Schwartz, D. R., & Morin, P. J. (2001) · PubMed · Cited by 277
CD24 Is Expressed in Ovarian Cancer and Is a New Independent Prognostic Marker of Patient Survival
Kristiansen, G., Denkert, C., Schlüns, K., Dahl, E., Pilarsky, C., & Hauptmann, S. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64398-2 · Cited by 261
Human Tissue Kallikreins: A Family of New Cancer Biomarkers
Diamandis, E. P., & Yousef, G. M. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.8.1198 · Cited by 247
Diamandis, E. P., Scorilas, A., Fracchioli, S., van Gramberen, M., de Bruijn, H., Henrik, A., Soosaipillai, A., Grass, L., Yousef, G. M., Stenman, U.-H., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.022 · Cited by 234
Plasminogen Activator Inhibitor Type 2 Inhibits Tumor Necrosis Factor α-induced Apoptosis
Dickinson, J. L., Bates, E. J., Ferrante, A., & Antalis, T. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27894 · Cited by 228
Terris, B., Blaveri, E., Crnogorac-Jurcevic, T., Jones, M., Missiaglia, E., Ruszniewski, P., Sauvanet, A., & Lemoine, N. R. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61121-2 · Cited by 225
Long, H., Crean, C., Lee, W. H., Cummings, O. W., & Gabig, T. G. (2001) · PubMed · Cited by 222
Overexpression of laminin gamma2 chain monomer in invading gastric carcinoma cells.
Koshikawa, N., Moriyama, K., Takamura, H., Mizushima, H., Nagashima, Y., Yanoma, S., & Miyazaki, K. (1999) · PubMed · Cited by 203
Genetic analysis of early- versus late-stage ovarian tumors.
Shridhar, V., Lee, J., Pandita, A., Iturria, S., Avula, R., Staub, J., Morrissey, M., Calhoun, E., Sen, A., Kalli, K., et al. (2001) · PubMed · Cited by 196
Osteopontin expression in lung cancer
Chambers, A. F., Wilson, S. M., Kerkvliet, N., O'Malley, F. P., Harris, J. F., & Casson, A. G. (1996) · Lung Cancer · doi:10.1016/0169-5002(95)00595-1 · Cited by 189
Zhan, F., Tian, E., Bumm, K., Smith, R., Barlogie, B., & Shaughnessy, J. (2003) · Blood · doi:10.1182/blood-2002-06-1737 · Cited by 164
Self-citationPrognostic relevance of plasminogen activators and their inhibitors in colorectal cancer.
Ganesh, S., Sier, C. F. M., Griffioen, G. G., Vloedgraven, H. J., de Boer, A., Welvaart, K., van de Velde, C. J. H., van Krieken, J. H., Verheijen, J. H., & Lamers, C. B. H. W. (1994) · PubMed · Cited by 159
Chambers, S. K., Kacinski, B. M., Ivins, C. M., & Carcangiu, M. L. (1997) · PubMed · Cited by 139
Kuhn, W. C., Pache, L., Schmalfeldt, B., Dettmar, P., Schmitt, M., Jänicke, F., & Graeff, H. (1994) · Gynecologic Oncology · doi:10.1006/gyno.1994.1313 · Cited by 138
The CD24/P-selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells.
Friederichs, J., Zeller, Y., Hafezi‐Moghadam, A., Gröne, H., Ley, K. F., & Altevogt, P. (2000) · PubMed · Cited by 131
Bratt, T. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(00)00154-0 · Cited by 128
Denhardt, D., Mistretta, D., Chambers, A., Krishna, S., Porter, J., Raghuram, S., & Rittling, S. (2004) · Clinical and Experimental Metastasis · doi:10.1023/a:1022550721404 · Cited by 115
CD24 Promotes Invasion of Glioma Cells In Vivo
Senner, V., Sturm, A., Baur, I., Schrell, U. M. H., Distel, L. V., & Paulus, W. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199908000-00002 · Cited by 112
Expression of the human nephron differentiation molecules in renal cell carcinomas.
Droz, D., Zachar, D., Charbit, L., Gogusev, J., Chrétein, Y., & Iris, L. R. (1990) · Europe PMC (PubMed Central) · Cited by 110
Shridhar, V., Sen, A., CHIEN, J. R., Staub, J. K., Avula, R. K., Kovats, S. G., Lee, J., Lillie, J., & Smith, D. I. (2002) · PubMed · Cited by 102
Zorn, K. K., Jazaeri, A. A., Awtrey, C. S., Gardner, G. J., Mok, S. C., Boyd, J. A., & Birrer, M. J. (2003) · PubMed · Cited by 101
CD24 is a marker for human breast carcinoma
Fogel, M., Friederichs, J., Zeller, Y., Husar, M., Smirnov, A., Roitman, L., Altevogt, P., & Sthoeger, Z. M. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00195-0 · Cited by 100
Retroposition in a Family of Carcinoma-Associated Antigen Genes
Linnenbach, A. J., Seng, B. A., Wu, S., Robbins, S. M., Scollon, M., Pyrc, J. J., Druck, T., & Huebner, K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.3.1507 · Cited by 98
Cellular and molecular targets of estrogen in normal human breast tissue.
Seth, P., PORTER, D. A., Lahti‐Domenici, J., Geng, Y., Richardson, A. L., & Polyák, K. (2002) · PubMed · Cited by 96
Schmalfeldt, B., Kühn, W. M., Reuning, U., et al. (1995) · PubMed · Cited by 95
Määttã, M., Virtanen, I., Burgeson, R. E., & Autio‐Harmainen, H. (2001) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540104900605 · Cited by 78
Santin, A. D., Bellone, S., Ravaggi, A., PECORELLI, S., CANNON, M. J., & Parham, G. P. (2000) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(00)00916-9 · Cited by 58
Self-citationExpression and prognostic significance of immunoregulatory molecules in esophageal cancer
Hosch, S. B., Izbicki, J. R., Pichlmeier, U., Stoecklein, N. H., Niendorf, A., Knoefel, W. T., Broelsch, C. E., & Pantel, K. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971219)74:6<571::aid-ijc2>3.0.co;2-r · Cited by 46
Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
Hasina, R., Hulett, K., Bicciato, S., Bello, C. D., Petruzzelli, G. J., & Lingen, M. W. (2003) · PubMed · Cited by 44
Tumour suppressor genes in sporadic epithelial ovarian cancer
Liu, Y., & Ganesan, T. (2002) · Reproduction · doi:10.1530/rep.0.1230341 · Cited by 24
Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer
Cannon, M. J., O’Brien, T. J., Underwood, L. J., Crew, M. D., Bondurant, K. L., & Santin, A. D. (2002) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2.1.97 · Cited by 21
Self-citation
Cited by
Hatakeyama, S. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3139 · Cited by 802
Claudin Proteins in Human Cancer: Promising New Targets for Diagnosis and Therapy
Morin, P. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2782 · Cited by 574
Drapkin, R., von Horsten, H. H., Lin, Y., Mok, S. C., Crum, C. P., Welch, W. R., & Hecht, J. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3924 · Cited by 570
Vang, R., Shih, I.-M., & Kurman, R. J. (2009) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e3181b4fffa · Cited by 562
Fader, A. N., Roque, D. M., Siegel, E., Buza, N., Hui, P., Abdelghany, O., Chambers, S. K., Secord, A. A., Havrilesky, L., O’Malley, D. M., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.5966 · Cited by 516
Self-citation
Metadata
- Authors
- Santin, A. D., Zhan, F., Bellone, S., Palmieri, M., Cane, S., Bignotti, E., Anfossi, S., Gokden, M., Dunn, D., Roman, J. J., O'Brien, T. J., Tian, E., Cannon, M. J., Shaughnessy, J., & Pecorelli, S.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2004-06-02
- Volume
- 112
- Issue
- 1
- Pages
- 14-25
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2007918447
- Cited by
- 313
- References
- 51
- FWCI
- 19.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.